Company intelligence / Profile preview

ACLARA BioSciences

Mountain View, California, USA

Ownership: Private
Development stage: Other

Overview

ACLARA BioSciences was a biotechnology company specializing in high-throughput, multiplexed assay technologies for drug discovery and personalized medicine. The company's core technology, the eTag assay system, utilized proprietary electrophoretic tags to enable the precise measurement of protein-protein interactions and protein phosphorylation in biological samples. This platform was primarily applied to oncology, helping to identify specific molecular signatures in tumors to guide the selection of targeted therapies. ACLARA was acquired by Monogram Biosciences in 2004, which was subsequently acquired by LabCorp in 2009.

Therapeutic areas: Oncology
Modalities: DiagnosticAssay technology
Industry: Protein Biomarker Diagnostics

Partnerships

GenentechGlaxoSmithKlineAstraZeneca

Beyond the preview

Go deeper on ACLARA BioSciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ACLARA BioSciences.

Explore the full profile